MedTrace Logo

To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet

NCT01764178 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2025-09-09

No results posted yet for this study

Summary

The purpose of this study is to compare pharmacokinetics between Pitavastatin and Valsartan co-administration and Livalo fixed combination drug in healthy male subjects.

Conditions

Interventions

DRUG

Livalo fixed combination drug

Pitavastatin 4mg / Valsartan 160mg

DRUG

Pitavastatin, Valsartan

Pitavastatin 4mg, Valsartan 160mg

Sponsors & Collaborators

Principal Investigators

  • Kyun Seop Bae, MD · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-22
Primary Completion
2013-03-15
Completion
2013-12-27

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01764178 on ClinicalTrials.gov